Puma Biotechnology, Inc. (PBYI)
5.73
+0.14
(+2.50%)
USD |
NASDAQ |
Dec 11, 16:00
5.74
+0.01
(+0.17%)
After-Hours: 20:00
Puma Biotechnology Research and Development Expense (Quarterly): 15.91M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Nephros, Inc. | 0.338M |
| Sensus Healthcare, Inc. | 1.819M |
| ACADIA Pharmaceuticals, Inc. | 87.83M |
| Vanda Pharmaceuticals, Inc. | 22.56M |
| Vertex Pharmaceuticals, Inc. | 977.70M |